Evidence of meeting #54 for Public Accounts in the 44th Parliament, 1st Session. (The original version is on Parliament’s site, as are the minutes.) The winning word was contracts.

A video is available from Parliament.

On the agenda

MPs speaking

Also speaking

Toshifumi Tada  President and Chief Executive Officer, Medicago Inc.
Patricia Gauthier  President, General Manager, Canada, Moderna Inc.
Najah Sampson  President, Pfizer Canada
Jean-Pierre Baylet  General Manager, Vaccines, Sanofi Canada
Michel Bédard  Interim Law Clerk and Parliamentary Counsel, Office of the Law Clerk and Parliamentary Counsel
Fabien Paquette  Vaccines Lead, mRNA Vaccines and Antiviral Portfolio, Pfizer Canada
Clerk of the Committee  Mr. Cédric Taquet

6 p.m.

President, Pfizer Canada

Najah Sampson

Thank you for the opportunity to clarify. Pfizer was not a part of the process. Again, we would have expressed our concerns if we had known that the unredacted contract would be provided to the AG.

6 p.m.

Conservative

Michael Kram Conservative Regina—Wascana, SK

The government just provided the unredacted documents to the Auditor General without your knowledge. After you found out it had happened, you then voiced your concerns. Am I understanding you correctly?

6 p.m.

President, Pfizer Canada

Najah Sampson

We would have voiced our concerns at that time.

6 p.m.

Conservative

Michael Kram Conservative Regina—Wascana, SK

You haven't voiced the concerns about the documents being given to the Auditor General, because what's past is past and it's water under the bridge. Is that correct?

6 p.m.

President, Pfizer Canada

Najah Sampson

That's correct.

6 p.m.

Conservative

Michael Kram Conservative Regina—Wascana, SK

Okay.

Did you communicate your concerns to the government about providing the unredacted documents to this committee?

That's to both of you.

6 p.m.

President, Pfizer Canada

Najah Sampson

Yes. We have discussed this in the past. I think both sides have agreed that the confidentiality clauses should be upheld in the contracts. I know that the government isn't here today to share its opinion, but it is worthwhile to understand its perspective.

6 p.m.

Conservative

Michael Kram Conservative Regina—Wascana, SK

Mr. Baylet.

6 p.m.

General Manager, Vaccines, Sanofi Canada

Jean-Pierre Baylet

I confirm that we requested that the unredacted version not be provided to this committee.

6 p.m.

Conservative

Michael Kram Conservative Regina—Wascana, SK

Who in particular did you talk with? Was it politicians? Was it civil servants? Could you elaborate, please?

6 p.m.

President, Pfizer Canada

Najah Sampson

I don't have those names, but I can come back to the committee with those names.

6 p.m.

General Manager, Vaccines, Sanofi Canada

Jean-Pierre Baylet

I don't have the names of the government staff members, but it was the Public Services and Procurement Canada team.

6 p.m.

Conservative

Michael Kram Conservative Regina—Wascana, SK

You can confirm that it was staff and not elected officials. Is that accurate?

6 p.m.

General Manager, Vaccines, Sanofi Canada

Jean-Pierre Baylet

That's right.

6 p.m.

Conservative

Michael Kram Conservative Regina—Wascana, SK

Okay. I see that Ms. Sampson is nodding.

Let's shift gears a bit to Bill C-290, which is the public sector integrity act. This is a bill that is before Parliament. It's about strengthening whistle-blower legislation.

Do any of the witnesses have any position on this particular bill?

6:05 p.m.

President, General Manager, Canada, Moderna Inc.

Patricia Gauthier

I just heard of the bill today. I have not had time to read it, but I can say that, in terms of governance, whistle-blowers and protecting people raising issues is very much aligned with the values of Moderna. I look forward to reading the bill and having further conversations.

6:05 p.m.

Conservative

The Chair Conservative John Williamson

That is the time, Mr. Kram.

I'll now turn to Mr. Housefather for five minutes.

You have the floor.

6:05 p.m.

Liberal

Anthony Housefather Liberal Mount Royal, QC

Thank you, Mr. Chair.

I want to come back to where we were. To start with, I think it's really important to have all of you here to convey what your position is and to get clarity on what that position is. We're talking in vague generalities—we want to protect this and we want to protect that—and I think it's important to get to very specifically what you want to protect and why, and the fear that you have. The fear that you have is clearly somehow that this committee will leak the document, because you would have suffered no damages in the event that the committee didn't breach confidentiality and it was only the members of the committee who had it.

I struggle a little bit to understand why you would trust the public servants more than the members of the committee, particularly when they would be in a room with the law clerk and wouldn't have access to any phone or any device to actually take a picture of the agreement or anything like that. It would be only their unaided memory that they could leave the room with, and then they would be in breach of the rules of Parliament if they actually divulged.

I want to come back then, to cut to the chase, to the agreement.

6:05 p.m.

Conservative

The Chair Conservative John Williamson

Mr. Housefather, I have a small point of clarification—I've stopped the clock—the law clerk is not part of the motion, just so you know.

6:05 p.m.

Liberal

Anthony Housefather Liberal Mount Royal, QC

I thought it was in his office.

March 23rd, 2023 / 6:05 p.m.

Conservative

The Chair Conservative John Williamson

It's the clerk's office, I believe.

6:05 p.m.

Liberal

Anthony Housefather Liberal Mount Royal, QC

The clerk's office...? Excuse me: It's the clerk, not the law clerk. Got it.

6:05 p.m.

Conservative

The Chair Conservative John Williamson

Exactly, yes.

Starting again, the time is yours.

6:05 p.m.

Liberal

Anthony Housefather Liberal Mount Royal, QC

Thank you, Mr. Chair.

Can I come back to it again? I really do want to understand, because I think where you have the concern is important. The concern is obviously only if somebody breaches.

Price, I understand. Price is a question and a competitive issue, and you don't want other countries to know what price you gave Canada. Also, some of my colleagues have talked about intellectual property. Again, I have very rarely, although on occasion.... I think, in the European Union leaked documents, there actually was some trade secret information that related to a process to manufacture the vaccine, but I would assume that wouldn't likely be in this contract. If it were, I could understand.

Again, if you had trade secret information related to the composition of the vaccine, how you process and manufacture the vaccine—although, again, I don't know why the government would need to know that—that would be information that would be very important not to have disclosed to competitors unless it was patented, in which case it would be public.

For Pfizer, please, other than that—other than price and trade secret information—what other clauses would be confidential?

6:05 p.m.

President, Pfizer Canada

Najah Sampson

Thank you for the question.

I think we're talking about protecting the entire agreement and the confidentiality of the entire agreement.